Published in N Engl J Med on September 28, 1950
Intracellular cation exchanges in metabolic alkalosis. J Clin Invest (1951) 1.42
Effects of potassium on renal tubular reabsorption of bicarbonate. J Clin Invest (1955) 1.28
Disturbances of ionic equilibrium of intracellular and extracellular electrolytes in patients with tuberculous meningitis. J Clin Invest (1952) 1.27
Intracellular and extracellular potassium deficits in surgical patients. Ann Surg (1952) 1.20
Experimental potassium depletion in normal human subjects. II. Renal and hormonal factors in the development of extracellular alkalosis during depletion. J Clin Invest (1959) 1.03
Electrolyte abnormalities in pyloric obstruction resulting from peptic ulcer or gastric carcinoma. Ann Surg (1952) 0.89
Hypokalemia as a cause of tetany. West J Med (1992) 0.78
The importance of potassium after operation. Calif Med (1953) 0.75
[Diagnosis and therapy of disorders in water and electrolyte metabolism after gynecological operations]. Arch Gynakol (1959) 0.75
Our present knowledge of potassium in physiological and pathological processes. Can Med Assoc J (1952) 0.75
HYPOKALAEMIA, URAEMIA, AND TETANY. Br Med J (1964) 0.75
Gynecomastia in adolescent boys. JAMA (1961) 2.41
Adrenocorticotropic hormone- and cortisone-induced regression of lymphoid tumors in man; a preliminary report. Cancer (1949) 2.09
1-Triiodothyronine versus 1-throxine; a comparison of their metabolic effects in human myxedema. Am J Med Sci (1953) 1.92
The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med (1962) 1.84
Conversion of testosterone to estrogens in castrated, adrenalectomized human females. J Biol Chem (1956) 1.84
Evaluation of endocrine therapy for advanced breast cancer. J Am Med Assoc (1954) 1.83
A diffusion method for the estimation of formaldehydogenic steroid. Endocrinology (1951) 1.77
The nature of the serum iodine after large doses of I131. J Clin Endocrinol Metab (1952) 1.76
The effect of bilateral adrenalectomy upon neoplastic disease in man. Cancer (1952) 1.68
Hypophysectomy in the treatment of metastatic mammary cancer. Am J Surg (1960) 1.56
Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias. J Am Med Assoc (1950) 1.53
Pituitary role in the estrogen dependency of experimental mammary cancer. Cancer Res (1963) 1.49
SKELETAL, INTESTINAL AND RENAL CALCIUM DYNAMICS IN HYPERPARATHYROIDISM. J Clin Endocrinol Metab (1963) 1.45
A new serum iodine component in patients with functional carcinoma of the thyroid. J Clin Endocrinol Metab (1955) 1.45
EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS. Am J Med (1964) 1.41
Adrenocortical hyperfunction in idiopathic hirsutism and the Stein-Leventhal syndrome. J Clin Invest (1958) 1.40
Effects of adrenal and gonadal products on the weight and radioiodine uptake of the thyroid gland in the rat. J Clin Endocrinol Metab (1950) 1.39
The effects of various steroids on the collection of radioactive iodine by the thyroid gland of the rat. Endocrinology (1951) 1.38
The metabolic effects of adrenocorticotropic hormone in a patient with Cushing's syndrome and acromegaly. J Clin Endocrinol Metab (1951) 1.38
The use of thiouracil in the treatment of metastatic carcinoma of the thyroid with radioiodine. J Clin Endocrinol Metab (1951) 1.30
Metabolism of L-thyroxine and L-3:5:3'-triiodothyronine by brain tissue preparations. Endocrinology (1957) 1.28
TUMORAL CALCINOSIS: A METABOLIC DISEASE OF OBSCURE ETIOLOGY. Am J Med (1965) 1.27
Studies with an adrenal inhibitor in adrenal carcinoma. J Clin Endocrinol Metab (1960) 1.27
Results of hypophysectomy in the treatment of metastatic mammary carcinoma. Cancer (1959) 1.25
An analysis of the polyuria induced by hypophysectomy in man. J Clin Endocrinol Metab (1956) 1.23
Hyperuricemia in myxedema. J Clin Endocrinol Metab (1960) 1.19
Hypophysectomy in the treatment of advanced cancer of breast. Ann Surg (1956) 1.16
Postoperative potassium deficit and metabolic alkalosis; the pathogenic significance of operative trauma and of potassium and phosphorus deprivation. J Clin Invest (1952) 1.15
Hypophysectomy in the treatment of advanced cancer. Trans Assoc Am Physicians (1955) 1.15
Effects of hypophysectomy in man. Med Clin North Am (1956) 1.13
The effect of thyroid-stimulating hormone in acute thyroiditis. J Clin Endocrinol Metab (1951) 1.13
CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER. Metabolism (1964) 1.12
Thyroid function following hypophysectomy in man. J Clin Endocrinol Metab (1955) 1.10
Radiation pneumonitis and fibrosis: a complication of radioiodine treatment of pulmonary metastases from cancer of the thyroid. J Clin Endocrinol Metab (1957) 1.09
Androgen-induced exacerbation of breast cancer measured by calcium excretion; conversion of androgen to estrogen as a possible underlying mechanism. J Am Med Assoc (1956) 1.09
The comparative effects of various steroids on lymphoid tissue of the rat. Cancer Res (1952) 1.08
Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer (1957) 1.08
Postoperative potassium deficit and metabolic alkalosis. N Engl J Med (1950) 1.07
Dosimetric considerations in determining hematopoietic damage from radioactive iodine. Am J Roentgenol Radium Ther Nucl Med (1953) 1.07
Physiological effects of bilateral adrenalectomy in man. Cancer (1952) 1.05
Metabolic and cytochemical changes produced by 6-mercaptopurine in human acute leukemia. Cancer (1956) 1.04
Resistance to corticotropin, cortisone, and folic acid antagonists in leukemia. J Am Med Assoc (1952) 1.02
URINARY EXCRETION OF PARATHYROID HORMONE IN MAN: EFFECTS OF CALCIUM LOADS, PROTEIN-FREE DIETS, ADRENAL CORTICAL STEROIDS AND NEOPLASTIC DISEASE. J Clin Endocrinol Metab (1965) 1.02
Myelophthisic anemia in cancer of the breast. Am J Med (1955) 1.02
Discussion of Dr. Huggins' paper: Control of cancers of man by endocrinological methods. Cancer Res (1957) 1.02
Endocrine therapy of metastatic breast cancer. AMA Arch Intern Med (1955) 1.00
Alterations in water and salt metabolism after bilateral adrenalectomy in man. J Clin Endocrinol Metab (1955) 1.00
Limitations and indications in the treatment of cancer of the thyroid with radioactive iodine. J Clin Endocrinol Metab (1951) 0.99
A study of "idiopathic" hirsutism; a transitional adrenal abnormality. J Clin Endocrinol Metab (1956) 0.99
Management of metastatic mammary cancer. J Am Med Assoc (1955) 0.97
Further studies of diabetes insipidus following hypophysectomy in man. J Lab Clin Med (1957) 0.97
The clinical expression of magnesium deficiency. JAMA (1960) 0.97
Studies on an iodinated protein in the serum of subjects with cancer of the thyroid. J Clin Endocrinol Metab (1956) 0.97
Metabolism of cardiac muscle; utilization of C14 labeled pyruvate and acetate by rat heart slices. Am J Physiol (1949) 0.96
Diabetes mellitus and carbohydrate metabolism in patients with cancer. Med Clin North Am (1956) 0.96
Comparative effects of thyroxine analogues in experimental animals. Ann N Y Acad Sci (1960) 0.93
Clinical and metabolic studies of bilateral adrenalectomy for advanced cancer in man. Surgery (1953) 0.93
Regulation of salt metabolism after hypophysectomy in man. J Clin Endocrinol Metab (1957) 0.93
The effect of various thyroxine analogues on suppression of I 131 uptake by the rat thyroid. Endocrinology (1959) 0.93
The effect of dl-3,3',5'-triiodothyronine in Graves' disease. J Clin Endocrinol Metab (1959) 0.92
Localized myxedema involving the upper extremities. Arch Intern Med (1963) 0.92
Uses and misuses of radioactive iodine in treatment of cancer of thyroid. AMA Arch Intern Med (1953) 0.91
The comparative metabolic effects of ACTH, cortisone acetate, and "compound F" acetate in a patient with chronic lymphatic leukemia. J Clin Invest (1950) 0.90
An unusual instance of thyroxine-binding by human serum gamma globulin. J Clin Endocrinol Metab (1956) 0.90
Adrenal estrogens in patients with metastatic breast cancer. J Clin Invest (1958) 0.90
HYPOPHYSECTOMY FOR THE TREATMENT OF DIABETIC RETINOPATHY. JAMA (1964) 0.90
The use of calcium 47 in diagnostic studies of patients with bone lesions. Am J Roentgenol Radium Ther Nucl Med (1961) 0.89
Immunologic measurement of growth hormone in human sera. J Clin Endocrinol Metab (1962) 0.88
ANTAGONISM BETWEEN PARATHYROID EXTRACT AND ADRENAL CORTICAL STEROIDS IN MAN. J Clin Endocrinol Metab (1965) 0.88
Medical management of adrenalectomy and hypophysectomy. AMA Arch Intern Med (1956) 0.88
A dissociation of thyroid hormonal effects by structural alterations of the thyroxine molecule. Am J Med Sci (1959) 0.87
The use of hydrocortisone in cancer. Ann N Y Acad Sci (1955) 0.86
PATHOGENESIS OF VITAMIN D-RESISTANT RICKETS AND THE RESPONSE TO A HIGH CALCIUM INTAKE. J Clin Endocrinol Metab (1963) 0.85
Adrenalectomy in the treatment of prostatic cancer. Geriatrics (1954) 0.85
Metabolic effects of ACTH in acute leukemia. J Clin Invest (1950) 0.85
The effects of p-hydroxypropiophenone on the thyroid gland of experimental animals. J Clin Endocrinol Metab (1951) 0.84
Today's thyroidologists and their beckoning frontiers. J Clin Endocrinol Metab (1956) 0.84
Persistent thyroid function following hypophysectomy. J Clin Endocrinol Metab (1960) 0.83
Endocrine treatment of metastatic breast cancer. Am Surg (1955) 0.83
GROWTH HORMONE LEVELS IN MATERNAL AND CORD BLOOD. J Clin Endocrinol Metab (1965) 0.82
Diabetogenic and hypoglycemic effects of human growth hormone. Trans Assoc Am Physicians (1960) 0.82
The effect of a thyrotrophic hormone preparation on the metabolism of radioiodine in euthyroid, hyperthyroid and acromegalic individuals. J Clin Invest (1953) 0.81
Metabolic effects in man of the acetic-acid analogues of thyroxine and triiodothyronine. J Clin Endocrinol Metab (1956) 0.81
Magnesium and calcium interrelationships. J Okla State Med Assoc (1960) 0.81
Treatment of psychiatric disorders with triiodothyronine. Am J Psychiatry (1958) 0.81
Sodium depletion in adrenalectomized humans. J Clin Invest (1958) 0.81
[Metabolic studies related to endocrine extirpative procedures]. Cancer (1958) 0.81
The clinical and physiologic effects of adrenocorticotropic hormone and cortisone acetate in patients with neoplastic disease. N Y State J Med (1951) 0.80
Hypophysectomy in treatment of advanced cancer. J Am Med Assoc (1956) 0.80
QUANTITATIVE OBSERVATIONS ON THE BIOLOGICAL AND IMMUNOLOGICAL ASSAYS OF HUMAN GROWTH HORMONE. Endocrinology (1964) 0.80